Abstract
Neurocysticercosis, caused by infection with the pork tapeworm Taenia solium, is increasingly recognized as a cause of neurologic disease worldwide. Because the clinical presentation is nonspecific, diagnosis has been difficult. Advances in imaging studies and serodiagnostic techniques are facilitating the diagnosis of neurocysticercosis and tapeworm carriers. Neurocysticercosis represents a spectrum of disease. Seizures are the main clinical manifestation in parenchymal neurocysticercosis. Recent studies emphasize that such seizures are the result of the host inflammatory response, even in patients who only have calcifications with no viable cysticerci. Controlled clinical trials have demonstrated that antiparasitic drugs can decrease the number of generalized seizures, although the benefit is small and confined to a subgroup of patients. Corticosteroids can also decrease seizure frequency. Case studies have demonstrated that endoscopic surgery appears to be the optimal approach to ventricular cysts. Recombinant vaccines are being developed and may prove important in disease control.
Similar content being viewed by others
References and Recommended Reading
White AC Jr: Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Ann Rev Med 2000, 51:187–206.
Garcia HH, Gonzalez AE, Evans CA, et al.: Taenia solium cysticercosis. Lancet 2003, 362:547–556. A broad overview of cysticercosis not limited to the CNS.
Zoli A, Shey-Njila O, Assana E et al.: Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. Acta Trop 2003, 87:35–42.
Phiri IK, Ngowi H, Afonso S, et al.: The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop 2003, 87:13–23.
Hira PR, Francis I, Abdella NA, et al.: Cysticercosis: imported and autochthonous infection in Kuwait. Trans R Soc Trop Med Hyg 2004, 98:233–239.
Townes JM, Hoffmann CJ, Kohn MA: Neurocysticercosis in Oregon, 1995–2000. Emerg Infect Dis 2004, 10:508–510.
Ong S, Talan DA, Moran GJ, et al.: Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis 2002, 8:608–613.
Del Brutto OH, Wadia NH, Dumas M, et al.: Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci 1996, 142:1–6.
Del Brutto OH, Rajshekhar V, White AC Jr, et al.: Proposed diagnostic criteria for neurocysticercosis. Neurology 2001, 57:177–183. The most recent consensus criteria for the diagnosis of neurocysticercosis from the Neurocysticercosis Working Group.
Garg RK: Diganostic criteria for neurocysticercosis: some modifications are needed for Indian patients. Neurol India 2004, 52:171–177.
Jeri C, Gilman RH, Lescano AG, et al.: Species identification after treatment for human taeniasis. Lancet 2004, 363:949–950.
Gonzalez LM, Montero E, Morakote N, et al.: Differential diagnosis of Taenia saginata and Taenia saginata asiatica taeniasis through PCR. Diagn Microbiol Infect Dis 2004, 49:183–188.
Yamasaki H, Allan JC, Sato MO, et al.: DNA differential diagnosis of taeniasis and cysticercosis by multiplex PCR. J Clin Microbiol 2004, 42:548–553.
Wilkins PP, Allan JC, Verastegui M, et al.: Development of a serologic assay to detect Taenia solium taeniasis. Am J Trop Med Hyg 1999, 60:199–204.
Levine MZ, Calderon JC, Wilkins PP, et al.: Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection. J Parasitol 2004, 90:631–638.
Hancock K, Pattabhi S, Greene RM, et al.: Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Mol Biochem Parasitol 2004, 133:115–124.
Kojic EM, White AC Jr: A positive enzyme-linked immunoelectrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis 2003, 36:e7-e9.
Hancock K, Khan A, Williams FB, et al.: Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. J Clin Microbiol 2003, 41:2577–2586.
Fleury A, Hernandez M, Fragoso G, et al.: Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg 2003, 97:542–546.
Mishra AM, Gupta RK, Jaggi RS, et al.: Role of diffusion-weighted imaging and in vitro proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 2004, 28:540–547.
Braga F, Rocha AJ, Gomes HR, et al.: Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis. Am J Neuroradiol 2004, 25:295–297.
Agarwal M, Chawla S, Husain N, et al.: Higher succinate than acetate levels differentiate cerebral degenerating cysticerci from anaerobic abscesses on in vivo proton MR spectroscopy. Neuroradiology 2004, 46:211–215.
Jayakumar PN, Srikanth SG, Chandrashekar HS, et al.: Pyruvate: an in vivo marker of cestodal infestation of the human brain on proton MR spectroscopy. J Magn Reson Imaging 2003, 18:675–680.
Chawla S, Gupta RK, Husain N, et al.: Prediction of viability of porcine neurocysticercosis with proton magnetic resonance spectroscopy: correlation with histopathology. Life Sci 2004, 74:1081–1092.
Garcia HH, Evans CA, Nash TE, et al.: Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002, 15:747–756. The most recent guidelines for the treatment of neurocysticercosis from the Neurocysticercosis Working Group.
Carpio A, Hauser WA: Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 2002, 59:1730–1734.
Garcia HH, Pretell EJ, Gilman RH, et al.: A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004, 350:249–258. A large, randomized clinical trial examining the role of antiparasitic medications in seizure reduction in patients with neurocysticercosis.
Singh G, Kaushal S, Gupta M, Chander Chopra S: Cutaneous reactions in patients with solitary cysticercus granuloma on phenytoin sodium. J Neurol Neurosurg Psychiatry 2004, 75:331–333.
Stringer JL, Marks LM, White AC Jr, Robinson P: Epileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol 2003, 183:532–536. This study documents the first animal model of seizures caused by neurocysticercosis to examine the contribution of the host immune response in epileptogenesis.
Rajshekhar V, Chandy MJ: Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol Scand 1997, 96:76–81.
Singhi P, Ray M, Singhi S, Khandelwal N: Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol 2000, 15:207–213.
Singhi P, Jain V, Khandelwal N: Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol 2004, 19:323–327.
Mall RK, Agarwal A, Garg RK, et al.: Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 2003, 44:1397–1401.
Garg RK, Kar AM, Singh MK: Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures. Headache 2004, 44:365–369.
Salinas R, Prasad K: Drugs for treating neurocysticercosis (tapeworm infection of the brain). Cochrane Database Syst Rev 2000, CD000215. A review of the medical treatment of neurocysticercosis.
Nash TE, Del Brutto OH, Butman JA, et al.: Calcific neurocysticercosis and epileptogenesis. Neurology 2004, 62:1934–1938. A review of the pathogenesis and treatment of the calcific form of the disease.
Garcia-Noval J, Moreno E, de Mata F, et al.: An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol 2001, 95:167–175.
Gupta RK, Kumar R, Chawla S, Pradhan S: Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia 2002, 43:1502–1508.
Wichert-Ana L, Velasco TR, Terra-Bustamante VC, et al.: Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Arch Neurol 2004, 61:1117–1119.
Torabi AM, Quiceno M, Mendelsohn DB, Powell CM: Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis. Arch Neurol 2004, 61:770–772.
Psarros TG, Krumerman J, Coimbra C: Endoscopic management of supratentorial ventricular neurocysticercosis: case series and review of the literature. Minim Invasive Neurosurg 2003, 46:331–334. A case series examining the role of minimally invasive endoscopic management of ventricular neurocysticercosis.
Bergsneider M, Holly LT, Lee JH, et al.: Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg 2000, 92:14–23.
Bergsneider M, Nieto JH: Endoscopic management of intraventricular cysticercosis. In Taenia solium Cysticercosis: From Basic to Clinical Science. Edited by Singh G and Prabhakar S. Oxford: CABI Publishing; 2002:399–410. An overview of the pathogenesis and management of intraventricular disease.
Proano JV, Madrazo I, Avelar F, et al.: Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001, 345:879–885.
Marquez-Caraveo C, Gongora-Rivera F, Santos Zambrano J, et al.: Pre-treatment with corticosteroids and a single cycle of high dose albendazole for subarachnoidal cysticercosis. J Neurol Neurosurg Psychiatry 2004, 75:938–939.
Delobel P, Signate A, El Guedj M, et al.: Unusual form of neurocysticercosis associated with HIV infection. Eur J Neurol 2004, 11:55–58.
Gonzalez AE, Garcia HH, Gilman RH, et al.: Control of Taenia solium. Acta Trop 2003, 87:103–109.
Lightowlers MW, Colebrook AL, Gauci CG, et al.: Vaccination against cestode parasites: anti-helminth vaccines that work and why. Vet Parasitol 2003, 115:83–123.
Flisser A, Gauci CG, Zoli A, et al.: Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 2004, 72:5292–5297.
Guo YJ, Sun SH, Zhang Y, et al.: Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine. Vaccine 2004, 22:3841–3847.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yancey, L.S., Diaz-Marchan, P.J. & White, A.C. Cysticercosis: Recent advances in diagnosis and management of neurocysticercosis. Curr Infect Dis Rep 7, 39–47 (2005). https://doi.org/10.1007/s11908-005-0022-0
Issue Date:
DOI: https://doi.org/10.1007/s11908-005-0022-0